Huang Z, Liu L, Zhang J, Conde K, Phansalkar J, Li Z, et al
And because the medications work by altering appetite signals, discontinuation frequently leads to weight regain, which highlights the importance of longterm planning and supportive lifestyle changes
Ozempics label expansion to include risk reduction of sustained eGFR decline, end-stage kidney disease, and cardiovascular death in adults with T2D and CKD may reframe nephrologists treatment decisions to initiate Ozempic in diabetic kidney disease
Several key barriers currently limit clinical translation
Many individuals find that Noom or Weightwatchers helps address eating patterns and accountability while GLP-1 medications manage appetite and metabolic factors